Biography

Nick Davies is an Associate in the Firm's International Corporate Practice Group.

Nick advises on a broad range of corporate matters including mergers and acquisitions, equity capital markets (AIM and Main Market), venture capital, private equity, corporate governance, and commercial agreements.

Nick also has experience advising charities and non-profit organizations, including The Design Museum, Facing History and Ourselves, and The Climate Crisis Foundation.

Representation

Acted for N+1 Singer on the initial public offering and admission of the entire issued share capital of Trellus Health Plc to trading on AIM, which raised approximately £28.5 million through a placing, US subscription, and restricted offer to shareholders.

Acted for Arbor Education Partners Group Ltd on its £30 million sale to The Key Support Services Limited.

Acted for Victoria P.L.C. on the £175 million investment in convertible redeemable preferred equity shares by Koch Equity Development LLC, a subsidiary of Koch Industries, Inc.

Acted for N+1 Singer on the initial public offering and admission of the entire issued share capital of Verici DX Plc to trading on AIM, which raised approximately £14.5 million through a placing, US subscription, and restricted offer to shareholders.

Acted for WANdisco plc, trading on AIM, in respect of a $42.46 million share placing via an accelerated bookbuild and subscription.

Acted for Nesta Impact Investments and Oxford Sciences Innovation in relation to their role as lead investors on the £7 million Series A financing of BibliU Limited, a UK-based digital learning platform.

Acted for Queensgate Investments in relation to their $400 million acquisition of Freehand Hotels, consisting of a portfolio of hotels in Manhattan, Miami Beach, Downtown Los Angeles, and Chicago.

Acted for RA Capital Management, LLC in relation to their role as lead investor on the £100 million Series B financing of Achilles Therapeutics UK Limited, a biopharmaceutical company developing personalized cancer immunotherapies.

Acted for Katsouris Brothers Limited, a Mediterranean food products business, on its £50 million sale to Cranswick plc.

Education

University of Law – LPC MSc Law, Business and Management, 2016
University of Birmingham – LLM Commercial Law, 2014
University of Birmingham – GDip Graduate Diploma in Law, 2013
London School of Economics – BSc Politics and Philosophy (Hons), 2012

Bar Admissions

Solicitor, England & Wales
Publications
Co-author, “SPACs: Listing Considerations and Latest Trends and Developments”, Brown Rudnick Alert (May 2021)
Co-author, “Litigation Funding: The Growth of a New Asset Class”, Intercontinental Finance & Law (October 2018)
Speaking Engagements
Co-host, “Tech Matters: Future Fund – Practical Steps for Applications," Brown Rudnick Podcast (May 2020)
Community Involvement
Volunteer with South West London Law Centres